Differential Pathophysiological Mechanisms of Stroke Evolution between New Lesions and Lesion Growth: Perfusion-Weighted Imaging Study

Background: Stroke evolution frequently occurs during the first week after stroke. However, the association between the type of stroke evolution and baseline perfusion severity has not been investigated. Methods: We analyzed clinical and serial MRI data on patients with acute middle cerebral artery infarcts. Multimodal MRIs were acquired before treatment and on day 7. Time to peak (Tmax) perfusion lesion maps were then generated, and changes in the day 7 diffusion-weighted imaging (DWI) were classified; new lesions were defined as new DWI lesions not contiguous with initial abnormalities, and infarct growth as enlargement of DWI lesions. Results: Among 74 patients (mean age 64.2 years), 51 received recanalization therapy. The day 7 DWI revealed the presence of new lesions in 39 cases (52.7%) and infarct growth (mean ± SD 20.0 ± 4.3 ml) in 52. No correlation was observed between new lesion and infarct growth (r = 0.029, p = 0.805). Most new lesions were multiple and small, located in cortical/superficial areas and within the mild perfusion delay (2 ≤ Tmax < 4 s) regions, whereas infarct growth generally occurred within the severer perfusion delay regions. Multiple regression analysis revealed that large mild perfusion delay was independently associated with new lesions, whereas large initial DWI lesions and a severer perfusion delay (4 ≤ Tmax < 8 s) were associated with infarct growth. In terms of treatment, endovascular therapy was associated with new lesions, whereas the degree of angiographic recanalization was inversely associated with infarct growth. Conclusions: The types of stroke evolution differed depending on the baseline hypoperfusion severity, and the mode and effect of recanalization therapy. A poor correlation was observed between new lesions and infarct growth.

[1]  J. Alger,et al.  Characteristics of Patients with Target Magnetic Resonance Mismatch Profile: Data from Two Geographically and Racially Distinct Populations , 2009, Cerebrovascular Diseases.

[2]  J. Alger,et al.  Impact of Reperfusion after 3 Hours of Symptom Onset on Tissue Fate in Acute Cerebral Ischemia , 2009, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[3]  J. Alger,et al.  MR Mismatch Profiles in Patients with Intracranial Atherosclerotic Stroke: A Comprehensive approach Comparing Stroke Subtypes , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[4]  R. Bammer,et al.  Optimal Tmax Threshold for Predicting Penumbral Tissue in Acute Stroke , 2009, Stroke.

[5]  J. Alger,et al.  Determinants of the distribution and severity of hypoperfusion in patients with ischemic stroke , 2008, Neurology.

[6]  Roland Bammer,et al.  Relationships Between Infarct Growth, Clinical Outcome, and Early Recanalization in Diffusion and Perfusion Imaging for Understanding Stroke Evolution (DEFUSE) , 2008, Stroke.

[7]  F Viñuela,et al.  Impact of collateral flow on tissue fate in acute ischaemic stroke , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[8]  P. Lee,et al.  Specific DWI lesion patterns predict prognosis after acute ischaemic stroke within the MCA territory , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[9]  M. Hennerici,et al.  Impaired Washout – Embolism and Ischemic Stroke: Further Examples and Proof of Concept , 2005, Cerebrovascular Diseases.

[10]  S. Warach,et al.  Early and late recurrence of ischemic lesion on MRI , 2004, Neurology.

[11]  Steven Warach,et al.  Trial design and reporting standards for intraarterial cerebral thrombolysis for acute ischemic stroke. , 2003, Journal of vascular and interventional radiology : JVIR.

[12]  S. Warach,et al.  Early ischemic lesion recurrence within a week after acute ischemic stroke , 2003, Annals of neurology.

[13]  Jeffry R Alger,et al.  Perfusion-Weighted Magnetic Resonance Imaging Thresholds Identifying Core, Irreversibly Infarcted Tissue , 2003, Stroke.

[14]  Jeffry R Alger,et al.  Late secondary ischemic injury in patients receiving intraarterial thrombolysis , 2002, Annals of neurology.

[15]  R. Knab,et al.  Cerebral Blood Flow Predicts Lesion Growth in Acute Stroke Patients , 2002, Stroke.

[16]  Mark W Parsons,et al.  Acute hyperglycemia adversely affects stroke outcome: A magnetic resonance imaging and spectroscopy study , 2002, Annals of neurology.

[17]  Stephen Rose,et al.  Diffusion‐ and perfusion‐weighted MRI response to thrombolysis in stroke , 2002, Annals of neurology.

[18]  E. Hauth,et al.  Diffusion-weighted MR imaging after angioplasty or angioplasty plus stenting of arteries supplying the brain. , 2001, AJNR. American journal of neuroradiology.

[19]  S M Davis,et al.  The value of apparent diffusion coefficient maps in early cerebral ischemia. , 2001, AJNR. American journal of neuroradiology.

[20]  C. Derdeyn Diffusion-weighted imaging as a surrogate marker for stroke as a complication of cerebrovascular procedures and devices. , 2001, AJNR. American journal of neuroradiology.

[21]  S M Davis,et al.  Perfusion Magnetic Resonance Imaging Maps in Hyperacute Stroke: Relative Cerebral Blood Flow Most Accurately Identifies Tissue Destined to Infarct , 2001, Stroke.

[22]  S. Warach,et al.  Effect of citicoline on ischemic lesions as measured by diffusion‐weighted magnetic resonance imaging , 2000 .

[23]  M. Hennerici,et al.  Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. , 1998, Archives of neurology.

[24]  R. Sacco,et al.  Risk factors for early recurrence after ischemic stroke: the role of stroke syndrome and subtype. , 1998, Stroke.

[25]  B. Rosen,et al.  High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis , 1996, Magnetic resonance in medicine.

[26]  S. Davis,et al.  Relationship between severity of MR perfusion deficit and DWI lesion evolution. , 2002, Neurology.

[27]  S. Warach,et al.  Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators. , 2000, Annals of neurology.